title: Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function.
authors.affiliation: Department of Respiratory Medicine, Royal Children's Hospital, Parkville, VIC, Australia; Murdoch Childrens Research Institute, Parkville, VIC, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia. Electronic address: john.massie@rch.org.au.
authors.forename: John
authors.initials: J
authors.lastname: Massie
authors.affiliation: Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Castellani
authors.affiliation: Departments of Pathology and Laboratory Medicine, Pediatrics, and Human Genetics, UCLA School of Medicine, Los Angeles, CA, USA.
authors.forename: Wayne W
authors.initials: WW
authors.lastname: Grody
mesh_terms: D000627:Aminophenols / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics* / Q000502:physiology; D006580:Genetic Carrier Screening / Q000379:methods*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods; D009154:Mutation; D015363:Quinolones / Q000627:therapeutic use
chemical_list: D000627:Aminophenols; D015363:Quinolones; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor